160 related articles for article (PubMed ID: 3705811)
1. [Measles morbidity among children inoculated against this infection].
Bolotovskiĭ VM; Gelikman BG; Mikheev IV; Titova NS; Kikosh GV
Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):38-43. PubMed ID: 3705811
[TBL] [Abstract][Full Text] [Related]
2. [The duration and strength of postvaccinal measles immunity].
Bolotovskiĭ VM; Gelikman BG; Auzinia AV; Glinskaia EV
Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):32-7. PubMed ID: 2386001
[TBL] [Abstract][Full Text] [Related]
3. [Immunological effectiveness of a booster inoculation against measles in children remaining seronegative after vaccination].
Bolomovskiĭ VM; Gelikman BG; Titova NS; Slavnitskaia IV; Auzinia AV
Zh Mikrobiol Epidemiol Immunobiol; 1984 Jul; (7):100-6. PubMed ID: 6333122
[TBL] [Abstract][Full Text] [Related]
4. [Immunostructure of school-age children inoculated against measles].
Bolotovskiĭ VM; Gelikman BG; Slavnitskaia IV; Glinskaia EV; Auzinia AV
Zh Mikrobiol Epidemiol Immunobiol; 1984 Feb; (2):83-7. PubMed ID: 6608840
[TBL] [Abstract][Full Text] [Related]
5. [The duration and intensity of measles immunity after a repeat inoculation against this infection].
Bolotovskiĭ VM; Mikheeva IV; Gelikman BG; Auzinia AV; Glinskaia EV
Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):45-9. PubMed ID: 2385988
[TBL] [Abstract][Full Text] [Related]
6. Measles outbreak in Ibadan: clinical, serological and virological identification of affected children in selected hospitals.
Adu FD; Ikusika A; Omotade O
J Infect; 1997 Nov; 35(3):241-5. PubMed ID: 9459395
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiologic effectiveness of mass revaccination against measles].
Deshevoĭ SE; Rykushin IuP; Ovsiannikova IV; Malykhina RM; Pogorelyĭ IuA
Zh Mikrobiol Epidemiol Immunobiol; 1988 Aug; (8):69-72. PubMed ID: 2973716
[TBL] [Abstract][Full Text] [Related]
8. [Duration of the preservation of postvaccinal immunity against measles and the results of a repeat immunization of children with various initial antibody levels].
Sokhin AA; Sliusar' LI; Popov VF; Noskov FS; Radomskaia FS
Zh Mikrobiol Epidemiol Immunobiol; 1983 Sep; (9):79-85. PubMed ID: 6637278
[TBL] [Abstract][Full Text] [Related]
9. The status of measles after five years of mass vaccination in the USSR.
Burgasov PN; Andzaparidze OG; Popov VF
Bull World Health Organ; 1973; 49(6):571-6. PubMed ID: 4548384
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
[No Abstract] [Full Text] [Related]
11. [Effectiveness of the selective revaccination of schoolchildren against measles].
Fel'dman EV; Kapustik LA; Belous TI; Bir'iak VN; Kuznetsova NK
Zh Mikrobiol Epidemiol Immunobiol; 1985 Jun; (6):30-4. PubMed ID: 2930972
[TBL] [Abstract][Full Text] [Related]
12. The role of secondary vaccine failures in measles outbreaks.
Mathias RG; Meekison WG; Arcand TA; Schechter MT
Am J Public Health; 1989 Apr; 79(4):475-8. PubMed ID: 2929807
[TBL] [Abstract][Full Text] [Related]
13. Immunity to measles before and after MMR booster or primary vaccination at 12 years of age in the first generation offered the 2-dose immunization programme.
Broliden K; Levén B; Arneborn M; Böttiger M
Scand J Infect Dis; 1998; 30(1):23-7. PubMed ID: 9670354
[TBL] [Abstract][Full Text] [Related]
14. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
Tischer A; Gerike E
Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
[TBL] [Abstract][Full Text] [Related]
15. Measles immunization. Successes and failures.
Yeager AS; Davis JH; Ross LA; Harvey B
JAMA; 1977 Jan; 237(4):347-51. PubMed ID: 576165
[TBL] [Abstract][Full Text] [Related]
16. [The strength of postvaccinal measles immunity in schoolchildren].
Smorodinova IP; Miroshnikova NK; Sobolevskaia AA
Tr Inst Im Pastera; 1985; 62():46-50. PubMed ID: 2954275
[No Abstract] [Full Text] [Related]
17. [The results of multiyear observations on the duration of the maintenance of immunity in those vaccinated and revaccinated against and recovered from measles].
Sliusar' LI; Sokhin AA; Radomskaia FS; Degtiareva GV; Panasenko LI; Litvinova TP; Komarevskaia RV; Bol'shinskaia ZhI
Zh Mikrobiol Epidemiol Immunobiol; 1990 Aug; (8):66-70. PubMed ID: 2239007
[TBL] [Abstract][Full Text] [Related]
18. [Rapid serological screening of human sera for the presence of measles virus antibodies in solid-phase immunoenzyme analysis].
Vedunova SL
Zh Mikrobiol Epidemiol Immunobiol; 1987 Sep; (9):81-5. PubMed ID: 3318248
[TBL] [Abstract][Full Text] [Related]
19. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
[TBL] [Abstract][Full Text] [Related]
20. [The immune status of children in foci of measles infection studied by an immunoenzyme method].
Iuminova NV; Unanov SS; Krasnova VP; Malancheva OA; Kovaleva LG; Liashenko VA
Zh Mikrobiol Epidemiol Immunobiol; 1990 Aug; (8):35-8. PubMed ID: 2239001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
